315 related articles for article (PubMed ID: 34575992)
21. Pediatric acute lymphoblastic leukemia.
Inaba H; Mullighan CG
Haematologica; 2020 Nov; 105(11):2524-2539. PubMed ID: 33054110
[TBL] [Abstract][Full Text] [Related]
22. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
23. Novel therapy for childhood acute lymphoblastic leukemia.
Santiago R; Vairy S; Sinnett D; Krajinovic M; Bittencourt H
Expert Opin Pharmacother; 2017 Aug; 18(11):1081-1099. PubMed ID: 28608730
[TBL] [Abstract][Full Text] [Related]
24. Novel antibody therapy in acute lymphoblastic leukemia.
Kochuparambil ST; Litzow MR
Curr Hematol Malig Rep; 2014 Jun; 9(2):165-73. PubMed ID: 24623281
[TBL] [Abstract][Full Text] [Related]
25. Updates in the biology and therapy for infant acute lymphoblastic leukemia.
Guest EM; Stam RW
Curr Opin Pediatr; 2017 Feb; 29(1):20-26. PubMed ID: 27841777
[TBL] [Abstract][Full Text] [Related]
26. New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.
Pierro J; Hogan LE; Bhatla T; Carroll WL
Expert Rev Anticancer Ther; 2017 Aug; 17(8):725-736. PubMed ID: 28649891
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
Kansagra A; Litzow M
Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
[TBL] [Abstract][Full Text] [Related]
28. [Adverse side effects of anticancer drugs in treatment of children with acute lymphoblastic leukemia].
Babak SV; Korzhenkov AA; Samarov NI; Boichenko EG; Goeva MA; Voloshina AY; Miftakhova VR; Pankina AN
Vopr Onkol; 2016; 62(5):596-605. PubMed ID: 30695583
[TBL] [Abstract][Full Text] [Related]
29. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
Kebriaei P; Poon ML
Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
[TBL] [Abstract][Full Text] [Related]
30. Advances in Supportive Care for Acute Lymphoblastic Leukemia.
Cook J; Litzow M
Curr Hematol Malig Rep; 2020 Aug; 15(4):276-293. PubMed ID: 32607955
[TBL] [Abstract][Full Text] [Related]
31. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
32. Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches.
Locatelli F; Moretta F; Rutella S
Curr Opin Oncol; 2013 Nov; 25(6):707-15. PubMed ID: 24076579
[TBL] [Abstract][Full Text] [Related]
33. Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target.
Ivanov AV; Alecsa MS; Popescu R; Starcea MI; Mocanu AM; Rusu C; Miron IC
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902091
[TBL] [Abstract][Full Text] [Related]
34. Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia.
Di Martino L; Tosello V; Peroni E; Piovan E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445444
[TBL] [Abstract][Full Text] [Related]
35. T-cell acute lymphoblastic leukemia: promising experimental drugs in clinical development.
Thomas X
Expert Opin Investig Drugs; 2023 Jan; 32(1):37-52. PubMed ID: 36541671
[TBL] [Abstract][Full Text] [Related]
36. Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020.
Rank CU; Schmiegelow K
Semin Hematol; 2020 Jul; 57(3):102-114. PubMed ID: 33256899
[TBL] [Abstract][Full Text] [Related]
37. Bispecific antibodies in acute lymphoblastic leukemia therapy.
Chitadze G; Laqua A; Lettau M; Baldus CD; Brüggemann M
Expert Rev Hematol; 2020 Nov; 13(11):1211-1233. PubMed ID: 33000968
[TBL] [Abstract][Full Text] [Related]
38. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
39. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia.
Hagag AA; Badraia IM; El-Shehaby WA; Mabrouk MM
J Oncol Pharm Pract; 2020 Sep; 26(6):1397-1406. PubMed ID: 31964219
[TBL] [Abstract][Full Text] [Related]
40. [Present status of individualized therapy in childhood acute lymphoblastic leukemia].
Wang J; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1617-22. PubMed ID: 24370059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
